Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

Ola Rizq, MD PhD, Naoya Mimura, MD PhD, Motohiko Oshima, PhD, Shuji Momose, MD PhD, Yaeko Nakajima-Takagi, PhD, Kazumasa Aoyama, PhD, Atsunori Saraya, Tohru Iseki, MD PhD, Emiko Sakaida, MD PhD, Chiaki Nakaseko, MDPhD, Yutaka Okuno, MD, PhD, Hiroaki Honda, MD PhD, Jun-ichi Tamaru, MDPhD, Atsushi Iwama, MD PhD

Blood (2018) 132 (Supplement 1): 1005.

https://doi.org/10.1182/blood-2018-99-114053

Published: 2018

Journal Articles

Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition

Eri Fujii, MT, Yuki Inada, Misaki Kakoki, Nao Nishimura, MD, Shinya Endo, MD, Shiho Fujiwara, MD, Naoko Wada, MD, Yawara Kawano, MD PhD, Yutaka Okuno, MD, PhD, Toshiya Sugimoto, MT, Hiroyuki Hata, MD PhD

Blood (2017) 130 (Supplement 1): 5395.

https://doi.org/10.1182/blood.V130.Suppl_1.5395.5395

Published: 2017

Journal Articles

Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin

Hiroyuki Hata, MD PhD, Toshiya Sugimoto, MT, Mitsuharu Ueda, MD, PhD, Nao Nishimura, MD, Shinya Endo, Yutaka Okuno, MD, PhD, Taro Yamashita, Konen Obayashi, MD, PhD, Masayoshi Tasaki, PhD, Eri Fujii, MT, Yuuki Inada, Misaki Kakoki, Yukio Ando, MD, PhD

Blood (2017) 130 (Supplement 1): 5331.

https://doi.org/10.1182/blood.V130.Suppl_1.5331.5331

Published: 2017

Journal Articles

Altered Expression of CCR10 Indicates Malignant Transformation of Bone Marrow Plasma Cells

Yawara Kawano, MD PhD, Misaki Kakoki, Yuki Inada, Nao Nishimura, MD, Yutaka Okuno, MD, PhD, Hiroyuki Hata, MDPhD, Masao Matsuoka, MDPhD

Blood (2017) 130 (Supplement 1): 1782.

https://doi.org/10.1182/blood.V130.Suppl_1.1782.1782

Published: 2017

Journal Articles

Role of PU.1 Down-Regulation for the Development of Primary Effusion Lymphoma

Hiroki Goto, MD, PhD, Ryusho Kariya, PhD, Eriko Kudo, PhD, Yutaka Okuno, MD, PhD, Seiji Okada, MD, PhD

Blood (2016) 128 (22): 4091.

https://doi.org/10.1182/blood.V128.22.4091.4091

Published: 2016

Journal Articles

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Niina Ueno, MD, Shikiko Ueno, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Hiro Tatetsu, MD PhD, Shinya Hirata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2015) 126 (23): 2957.

https://doi.org/10.1182/blood.V126.23.2957.2957

Published: 2015

Journal Articles

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Shinya Endo, MD, Hiromichi Yuki, MD PhD, Yoshihiro Komohara, MD PhD, Shikiko Ueno, MD PhD, Nao Nishimura, MD, Niina Ueno, MD, Hiro Tatetsu, MD PhD, Motohiro Takeya, MD PhD, Hiroyuki Hata, MD PhD, Seiji Okada, MD PhD, Daniel G. Tenen, MD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 29.

https://doi.org/10.1182/blood.V124.21.29.29

Published: 2014

Journal Articles

Deposition of Lambda Chain Constant Region within AL-Amyloid Lesion

Hiroyuki Hata, MD PhD, Masayoshi Tasaki, Konen Obayashi, MD PhD, Taro Yamashita, MD PhD, Yukio Ando, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Yutaka Okuno, MD PhD, Shiho Fujiwara, MD PhD, Naoko Wada, MD, Eri Fujii, Kennichi Iyama, MD PhD, Hiroaki Mitsuya, MD PhD

Blood (2014) 124 (21): 3348.

https://doi.org/10.1182/blood.V124.21.3348.3348

Published: 2014

Journal Articles

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

Nao Nishimura, MD, Shinya Endo, MD, Niina Ueno, MD, Shikiko Ueno, MD PhD, Hiromichi Yuki, MD PhD, Hiroyuki Hata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 2047.

https://doi.org/10.1182/blood.V124.21.2047.2047

Published: 2014

Journal Articles

A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells

Naoko Wada, MD, Yawara Kawano, MD, PhD, Shiho Fujiwara, MD, Yoshitaka Kikukawa, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hiroyuki Hata, MD, PhD

Blood (2013) 122 (21): 3172.

https://doi.org/10.1182/blood.V122.21.3172.3172

Published: 2013

Journal Articles

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2013) 122 (21): 4977.

https://doi.org/10.1182/blood.V122.21.4977.4977

Published: 2013

Journal Articles

Accumulation Of Gene Alterations Of TP53 , Crebbp and IKZF1 Is a Prognostic Factor In Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichro Yamaguchi, MD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD

Blood (2013) 122 (21): 1386.

https://doi.org/10.1182/blood.V122.21.1386.1386

Published: 2013

Journal Articles

Monocarboxylate Transporters Play an Important Role in Aerobicglycolysis in Multiple Myeloma

Shiho Fujiwara, MD, Naoko Wada, MD, Yawara Kawano, MD, Hiromichi Yuki, MD, Yutaka Okuno, MD, PhD, Kisato Nosaka, MD, PhD, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2012) 120 (21): 1821.

https://doi.org/10.1182/blood.V120.21.1821.1821

Published: 2012

Journal Articles

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

Hiromichi Yuki, MD, Shikiko Ueno, MD, PhD, Hiroaki Niiro, MD, PhD, Hiro Tatetsu, MD, PhD, Hiroyuki Hata, MD, PhD, Toshiki Watanabe, MD, PhD, Seiji Okada, MD, Ph.D, Koichi Akashi, MD, PhD., Hiroaki Mitsuya, Professor, Yutaka Okuno, MD, PhD

Blood (2011) 118 (21): 2628.

https://doi.org/10.1182/blood.V118.21.2628.2628

Published: 2011

Journal Articles

Decreased CD138 Expression in Myeloma Cells: A Potential Indicator of Poor Prognosis and Aberrant Differentiation,

Yawara Kawano, MD, Shiho Fujiwara, MD, Hiromichi Yuki, MD, Hiro Tatetsu, MD, PhD, Hiroshi Yamasaki, MD, PhD, Akira Sakai, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hiroyuki Hata, MD, PhD

Blood (2011) 118 (21): 3939.

https://doi.org/10.1182/blood.V118.21.3939.3939

Published: 2011

Journal Articles

Aerobic Glycolysis: A Possible Target for Treating Multiple Myeloma (MM) with High Serum LDH Levels

Shiho Fujiwara, MD, Yawara Kawano, MD, Hiromichi Yuki, MD, Yutaka Okuno, MD, PhD, Kisato Nosaka, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hiroyuki Hata, MD, PhD

Blood (2011) 118 (21): 1799.

https://doi.org/10.1182/blood.V118.21.1799.1799

Published: 2011

Journal Articles

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

Yawara Kawano, Shikiko Ueno, Masahiro Abe, MD, Yoshitaka Kikukawa, Hiromichi Yuki, Kenichi Iyama, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 2975.

https://doi.org/10.1182/blood.V116.21.2975.2975

Published: 2010

Journal Articles

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Yawara Kawano, Yoshitaka Kikukawa, Miki Nakamura, Yutaka Okuno, MD, PhD, Hiromichi Yuki, Shiho Fujiwara, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 616.

https://doi.org/10.1182/blood.V116.21.616.616

Published: 2010

Journal Articles

PU.1 Is Downregulated in a Subset of Multiple Myeloma by the Methylation of Its -17 kb Upstream Regulatory Region and the Promoter.

Yutaka Okuno, MD, PhD, Hiro Tatetsu, MD.PhD., Shikiko Ueno, MD., Hiroyuki Hata, MD.PhD., Yasuhiro Yamada, MD.PhD., Motohiro Takeya, MD.PhD., Tadafumi Iino, MD, Koichi Akashi, MD.PhD., Daniel G. Tenen, MD., Hiroaki Mitsuya, MD.PhD.

Blood (2006) 108 (11): 3417.

https://doi.org/10.1182/blood.V108.11.3417.3417

Published: 2006

Journal Articles

3′ Distal Regulatory Elements Required for Human CD34 Expression in Transgenic Mice.

Elena Levantini, PhD, Yutaka Okuno, MD, PhD, Pu Zhang, MD, Steffen Koschmieder, MD, Hanna S. Radomska, PhD, Maris Fenyus, Maureen Guiney, Daniel G. Tenen, MD

Blood (2005) 106 (11): 125.

https://doi.org/10.1182/blood.V106.11.125.125

Published: 2005

NARROW

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition

Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin

Altered Expression of CCR10 Indicates Malignant Transformation of Bone Marrow Plasma Cells

Role of PU.1 Down-Regulation for the Development of Primary Effusion Lymphoma

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Deposition of Lambda Chain Constant Region within AL-Amyloid Lesion

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Accumulation Of Gene Alterations Of TP53 , Crebbp and IKZF1 Is a Prognostic Factor In Adult Acute Lymphoblastic Leukemia

Monocarboxylate Transporters Play an Important Role in Aerobicglycolysis in Multiple Myeloma

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

Decreased CD138 Expression in Myeloma Cells: A Potential Indicator of Poor Prognosis and Aberrant Differentiation,

Aerobic Glycolysis: A Possible Target for Treating Multiple Myeloma (MM) with High Serum LDH Levels

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

PU.1 Is Downregulated in a Subset of Multiple Myeloma by the Methylation of Its -17 kb Upstream Regulatory Region and the Promoter.

3′ Distal Regulatory Elements Required for Human CD34 Expression in Transgenic Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only